entertainment -WSS

entertainment

author：comprehensive 2025-09-29 10:34:41 - browse：9

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Biotech venture capitalists face new demands from investors

explore

WSS

Chinese researcher claims birth of first gene

Cancer, immunology, HIV research ensnared in fetal tissue politics

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Asbestos ban is immediate, but health effects will linger for decades

Readout Newsletter: Illumina, CRISPR, Regeneron

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

entertainment

entertainment

focus

The high cost of giving birth even with insurance

New brain studies show LSD's effects on the brain in full color

Cancer drug shortages should be causing more outrage

Francis Collins on trust in science and how Covid communications failed

Walensky prepares to leave CDC — and Congress — behind

Testing GLP

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

EU regulator recommends expanding Mounjaro approval to obesity

Hollywood unions extend contract negotiations for actors

Readout LOUD podcast, live from the STAT Breakthrough Summit East

hotspot

Parkinson’s finding may lead to tests and, someday, treatments

Research misconduct: Proposed new rules face resistance

eGenesis tests gene

Medical devices makers are asking for forgiveness, not permission

Texas board proposes rules on abortion law emergency exemption

EU regulator recommends expanding Mounjaro approval to obesity

knowledge

hotspot

explore

entertainment